6785.TWO
Price:
$288
Market Cap:
$19.24B
Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. It is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid use disorder; ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; ALA-4000 which is in pre-clinical stage for treatment of Parkinson's disease; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-10-05
Stock Exchange
TWO
Ticker
6785.TWO
According to Alar Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.41B. This represents a change of 82.82% compared to the average of 9.52B of the last 4 quarters.
The mean historical Enterprise Value of Alar Pharmaceuticals Inc. over the last ten years is 3.88B. The current 17.41B Enterprise Value has changed 44.77% with respect to the historical average. Over the past ten years (40 quarters), 6785.TWO's Enterprise Value was at its highest in in the March 2024 quarter at 20.41B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.
Average
3.88B
Median
1.99B
Minimum
0
Maximum
11.27B
Discovering the peaks and valleys of Alar Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 11.27B
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 8.12B | -27.94% |
| 2023 | 11.27B | 84.60% |
| 2022 | 6.10B | 192.03% |
| 2021 | 2.09B | 10.80% |
| 2020 | 1.89B | 19.75% |
| 2019 | 1.57B | Infinity% |
| 2018 | 0 | 0% |
The current Enterprise Value of Alar Pharmaceuticals Inc. (6785.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.49B
5-year avg
5.89B
10-year avg
3.88B
Alar Pharmaceuticals Inc.’s Enterprise Value is greater than Grape King Bio Ltd (15.97B), greater than Handa Pharmaceuticals, Inc. (14.70B), less than Synmosa Biopharma Corporation (17.83B), less than TTY Biopharm Company Limited (20.56B), greater than YungShin Global Holding Corporation (15.23B), greater than Foresee Pharmaceuticals Co., Ltd. (11.85B), greater than ScinoPharm Taiwan, Ltd. (11.68B), greater than TaiMed Biologics Inc. (16.82B), less than EirGenix Inc. (17.73B), less than Great Tree Pharmacy Co., Ltd. (19.79B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 15.97B | $18.89B | |
| 14.70B | $15.56B | |
| 17.83B | $16.12B | |
| 20.56B | $20.89B | |
| 15.23B | $15.29B | |
| 11.85B | $12.36B | |
| 11.68B | $13.76B | |
| 16.82B | $17.16B | |
| 17.73B | $19.21B | |
| 19.79B | $14.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alar Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alar Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alar Pharmaceuticals Inc.'s Enterprise Value?
What is the highest Enterprise Value for Alar Pharmaceuticals Inc. (6785.TWO)?
What is the 3-year average Enterprise Value for Alar Pharmaceuticals Inc. (6785.TWO)?
What is the 5-year average Enterprise Value for Alar Pharmaceuticals Inc. (6785.TWO)?
How does the current Enterprise Value for Alar Pharmaceuticals Inc. (6785.TWO) compare to its historical average?